Hemophilia gene therapy priced at $2.9 million
ADC评论
November 4, 2022
On November 3, the Institute of Clinical and Economic Review (ICER) announced that, after a cost-benefit analysis, it assessed the price ceiling of Roctavian (valoctocogene
